
Zhanna Jumadilova, MD, MBA
Advertisement
Articles by Zhanna Jumadilova, MD, MBA
Advertisement
Latest Updated Articles
Persistence With Overactive Bladder Pharmacotherapy in a Medicaid PopulationPublished: July 15th 2005 | Updated:
Medical Costs After Initiation of Drug Treatment for Overactive Bladder: Effects of Selection Bias on Cost EstimatesPublished: July 15th 2005 | Updated:
Urinary Incontinence in the Nursing Home: Resident Characteristics and Prevalence of Drug TreatmentPublished: July 15th 2005 | Updated:
Treatment of Overactive Bladder: A Model Comparing Extended-release Formulations of Tolterodine and OxybutyninPublished: July 15th 2005 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Ocrelizumab Leads to Lower Hospitalization Rates Compared to Rituximab in MS
2
Zanubrutinib Shows Similar Efficacy but Better Safety Than VEN–I in Frontline CLL
3
Mirvetuximab Soravtansine Demonstrates Promising Efficacy, Safety in Platinum-Resistant Recurrent Ovarian Cancer
4
The Changing Treatment Landscape of IPF and PPF: Toby Maher, MD, PhD
5



